Switzerland eases access to prescription medicines
This article was originally published in OTC Bulletin
Executive Summary
Swiss consumers will soon be able to buy a number of prescription-only medicines without a prescription through pharmacy – such fluticasone, ketotifen and desloratadine – following the latest revisions to the country’s medicines regulation, the HMG.
You may also be interested in...
Swiss Regulatory Change Takes Over 500 OTCs Out Of Pharmacy
Swiss medicines authority, Swissmedic, rules that hundreds of non-prescription medicines are safe to be purchased outside pharmacy, following the completion of its review of the country's medicines classification system.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.